Acute liver failure

Current Treatment Options in Gastroenterology

Volumn 7, Issue 6, 2004, Pages 459-468

  Hay, J Eileen ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACICLOVIR; ACTIVATED CARBON; AMINO ACID; ANTIBIOTIC AGENT; ANTIDOTE; ANTIFUNGAL AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CORTICOSTEROID; DIAZEPAM; FLUCONAZOLE; HERBACEOUS AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; ISONIAZID; LACTULOSE; LAMIVUDINE; LORAZEPAM; MANNITOL; NEOMYCIN; OSMOTIC AGENT; PARACETAMOL; PENICILLIN G; PHENYTOIN; PROPOFOL; PROPYLTHIOURACIL; PROTON PUMP INHIBITOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SILIBININ; UNINDEXED DRUG;

ANAMNESIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL FEATURE; CLINICAL TRIAL; COMA; DEATH; DIALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG INDICATION; DRUG OVERDOSE; EARLY DIAGNOSIS; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; ENTERIC FEEDING; HEALTH CARE FACILITY; HEMODYNAMICS; HEPATITIS; HUMAN; HYPERVENTILATION; INDUCED HYPOTHERMIA; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; KIDNEY FAILURE; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; MEDICAL EXPERT; MORTALITY; ORGAN DONOR; PATIENT MONITORING; PATIENT TRANSPORT; PROGNOSIS; RESTLESSNESS; SCREENING TEST; SEDATION; SEIZURE; SHORT COURSE THERAPY; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS HEPATITIS;

EID: 9744285801     PISSN: 10928472     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11938-004-0005-5     Document Type: Article

References (58)

1. Lee WM: Acute liver failure. Clin Perspectives Gastroenterol 2001, 101-110.
2. Sass DA, Shakil AO: Fulminant hepatic failure. Gastroenterol Clin North Am 2003, 32:1195-1211.
3. Ostapowicz G, Fontana RJ, Schiodt FV, et al.: Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002, 137: 47-954.
4. Schiodt FV, Davern TJ, Shakil AO, et al.: Vital hepatitis-related acute liver failure. Am J Gastroenterol 2003, 98:448-453.
5. Lee WM: Drug-induced hepatotoxicity. N Eng J Med 2003, 349:474-485.
6. Stedman C: Herbal hepatotoxicity. Semin Liver Dis 2002, 22:195-206.
7. Estes JD, Stolpman D, Olyaei A, et al.: High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch Surg 2003, 138: 52-858.
8. Russo MW, Glanako JA, Shrestha R, et al.: Liver transplantation for acute liver failure from drug induced liver injury in the United States. {AU: Please supply journal title} 2004, 10: 018-1023.
9. Sharma S, Mosunjac M: Herpes simplex hepatitis in adults. Gastroenterol 2004, 38:697-704.
10. Roberts EA, Schilsky ML: A practice guideline on Wilson disease. Hepatology 2003, 37:1475-1492.
11. Brok J, Buckley N, Gluud C: Interventions for paracetamol (acetaminophen) overdoses. Cochrane Database Syst Rev 2002, 3:CD003328.
12. Sato RL, Wong JJ, Sumida SM, et al.: Efficacy of superactivated charcoal administered late (3 hours) after acetaminophen overdose. Am J Emerg Med 2003, 21:189-191.
13. Czaja AJ, Freese DK: Diagnosis and treatment of autoimmune hepatitis. Hepatology 2002, 36:479-497.
14. Ch'ng CL, Morgan M, Hainsworth I, Kingham JG: Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002, 51:867-880.
15. Rahman TM, Wendon J: Severe hepatic dysfunction in pregnancy. QJM 2002, 95:343-357.
16. Peters DJ, Greene WH, Ruggiero E, McGarrity TJ: Herpes simplex-induced fulminant hepatitis in adults: a call for empiric therapy. Dig Dis Sci 2000, 45:2399-2404.
17. Enhalbert F, Rapior S, Nouguier-Soule J, et al.: Treatment of amatoxin poisoning: 20-year retrospective analysis. J Toxicol 2002, 40:715-757.
18. Lee WC, Wu MJ, Cheng CH, et al.: Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis 2001, 38:1074-1081.
19. Walsh TS, Wigmore SJ, Hopton P, et al.: Energy expenditure in acetaminophen-induced fulminant hepatic failure. Crit Care Med 2000, 28:649-654.
20. Rolando N, Wade J, Davalos M, et al.: The systemic inflammatory response syndrome in acute liver failure. Hepatology 2002, 32:734-739.
21. Vaquero J, Polson J, Chung C, et al.: Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 2003, 125:755-764.
22. Jalan R, Williams R: The inflammatory basis of intracranial hypertension in acute liver failure. J Hepatol 2001, 34:940-942.
23. Rolando N, Wade JJ, Stangou A, et al.: Prospective study comparing the efficacy of prophylactic parenteral antimcrobials, with or without enteral decontamination, in patients with acute liver failure. Liver Transpl Surg 1996, 2:8-13.
24. Fisher NC, Cooper MA, Hastings JGM, et al.: Fungal colonisation and fluconazole therapy in acute liver disease. Liver 1998, 18:320-325.
25. Shami VM, Caldwell SH, Hespenheide EE, et al.: Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 2003, 9:138-143.
26. Blei AT, Larsen FS: Pathophysiology of cerebral edema in fulminant hepatic failure. J Hepatol 1999, 31:771-776.
27. Larsen FS, Wendon J: Brain edema in liver failure: basic physiologic principles and management. Liver Transpl 2002, 8: 83-989.
28. Vaquero J, Chung C, Cahill ME, Blei AT: Pathogenesis of hepatic encephalopathy in acute liver failure. Semin Dis 2003, 23:259-269.
29. Jalan R, Olde Damink SWM, Deutz NEP, et al.: Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia. Hepatology 2001, 34:50-54.
30. Blei A: Medical therapy of brain edema in fulminant hepatic failure. Hepatology 2000, 32:666-669.
31. Rose C, Michalak A, Pannunzio M, et al.: Mild hypothermia delays onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure. Hepatology 2000, 31:872-877.
32. Clemmesen JO, Larsen FS, Kondrup J, et al.: Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999, 29: 48-653.
33. Alba L, Hay JE, Angulo P, Lee WM: Lactulose therapy in acute liver failure. J Hepatol 2002, 36:33A.
34. Strauss G, Hansen BA, Knudsen GM, Larsen FS: Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. J Hepatol 1998, 28:199-203.
35. Ede RJ, Gimson AES, Bihari D, Williams R: Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 1986, 2:43-51.
36. Canalese J, Gimson AES, Davis C, et al.: Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982, 23:625-629.
37. Butterworth RF: Mild hypothermia prevents cerebral edema in acute liver failure. J Hepatobiliary Pancreat Surg 2001, 8:16-19.
38. Jalan R, Damink SWMO, Duetz NEP, Lee A, Hayes PC: Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999, 354:1164-1168.
39. Jalan R, Olde Damink SWM: Hypothermia for the management of intracranial hypertension in acute liver failure. Curr Opin Crit Care 2001, 7:257-262.
40. Jalan R, Olde Damink SWM, Duetz NEP, et al.: Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation 2003, 75:2034-2039.
41. Murphy N, Auzinger G, Bernel W, Wendon J: The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004, 39:464-470.
42. Larsen Fs, Hansen BA, Blei AT: Intensive care management of patients with acute liver failure with emphasis on systemic hemodynamic instability and cerebral edema: a critical appraisal of pathophysiology. Can J Gastroenterol 2000, 14:105D-111D.
43. Davenport A: s there a role for continuous renal replacement therapies in patients with liver and renal failure? Kidney Int 1999, 72:S62-S66.
44. Shawcross DL, Davies NA, Mookerjee RP, et al.: Worsening of cerebral hyperemia by the administration of Terlipressin in acute liver failure with severe encephalopathy. Hepatology 2004, 39:471-475.
45. Wijdicks EFM, Nyberg SL: Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc 2002, 34:1220-1222.
46. Ellis AJ, Wendon JA, Williams R: Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 2000, 32:536-541.
47. Bhatia V, Batra Y, Acharya SK: Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure - a controlled clinical trial. Hepatology 2004, 41:89-96.
48. Nyberg SL, Matsushita T, Gores G, et al.: The role of cell-based bioartificial liver therapy in the treatment of fulminant hepatic failure. Graft 2002, 5:374-382.
49. Jalan R, Sen S, Williams R: Prospects for extracorporeal liver support. Gut 2004, 53:890-898.
50. Demetriou AA, Brown RS, Busuttil RW, et al.: Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004, 239: 60-670.
51. Roberts MS, Angus DC, Bryce CL, et al.: Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004, 10: 86-897.
52. Bernal W, Donaldson N, Wyncoll D, Wendon J: Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002, 359:558-563.
53. Brandsater B, Hockerstedt K, Friman S, et al.: Fulminant hepatic failure: outcome after listing for highly urgent liver transplantation - 12 years experience in the Nordic Countries. Liver Transpl 2002, 8:1055-1062.
54. O'Grady JG, Alexander GJM, Hayllar KM, Williams R: Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989, 97:439-45.
55. Riordan SM, Williams R: Use and validation of selection criteria for liver transplantation in acute liver failure. Liver Transpl 2000, 6:170-173.
56. Bailey B, Amre DK, Gaudreault P: Fulminant hepatic failure secondary to acetaminophen poisoning a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 2003, 31:299-305.
57. Shakil AO, Kramer D, Mazariegos CV, et al.: Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 2000, 6:163-169.
58. Rezende G, Roque-Afonso AM, Samuel D, et al.: Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 2003, 38:613-618.